JD Supra

Method of Treatment Claim’s Limiting Preamble Must Satisfy the Written Description Requirement

On March 13, 2025, the U.S. Court of Appeals for the Federal Circuit issued a decision in the case of In Re: Xencor, Inc. 1 In this Appeal from the Appeals Review Panel of the Patent Trial and Appeal ...
JD Supra

Patentee Secures Reversal of JMOL on Written Description and Enablement for Method of Treatment by Administering Genus of Antibodies at Federal Circuit

Today the Federal Circuit reversed a district court’s JMOL and held that claims to a method of treating headaches using a genus of antagonistic anti-CGRP antibodies satisfied both the written ...